"WORK: The work performed on the TNF-RSC can be summarised in 7 different subprojects:
1) DETERMINATION OF TNF-RSC COMPOSITION: We performed a comprehensive, quantitative mapping of the TNF-RSC composition and identification of the new complex members by mass spectrometry using data dependent acquisition (DDA), data-independent acquisition (DIA) and parallel reaction monitoring (PRM) approaches. To achieve this goal, an extensive biochemical optimisation to natively isolate the TNF-RSC from cells has been carried out.
2) DYNAMICS OF TNF-RSC FORMATION: The composition (point #1) has been determined over the course of 4 different time points, providing an unprecedented view of the assembly and disassembly of this signaling platform over time.
3) TNF-RSC NEW MEMBERS FUNCTIONAL CHARACTERIZATION: As part of point #2, we identified two new putative members of the TNF-RSC. We carried out functional validation of these two new factors by several different means, including reciprocal pulldowns, knockdown (siRNA), knockout (CRISPR/Cas9), apoptosis assays and bioinformatics analyses.
4) TNF-RSC STOICHIOMETRY: We performed a first-ever time-resolved stoichiometry determination of the TNF-RSC holo-complex and subcomplexes by mass spectrometry using absolute quantification (AQUA). This is, to our knowledge, one of the the largest mass spectrometry absolute quantification study ever carried out on specific protein complex or signaling platform.
5) TNF-RSC IN SPACE: We developed a protocol to combine native affinity purification of the TNF-RSC wi the separation of protein subcomplexes with blue native page (BNPAGE), in conjunction with targeted mass spectrometry. This has allowed us to define different subcomplexes of the TNF-RSC, define their space-resolved composition and approximate molecular weight.
6) TNF-RSC PROXIMITY LABELING: Systematic interaction mapping by affinity purification coupled to mass spectrometry (AP-MS) and proximity labeling (BioID) of one of the key subcomplexes of the TNF-RSC, LUBAC. Functional validation of targets is ongoing.
7) TNFRI MEMBRANE PROTEOME: We applied an unpublished protocol to label membrane proteins proximal to the TNF-R1 and identification of new candidates that may be involved in the regulation of the receptor’s activity (in collaboration with the Wollscheid Lab, ETH).
Many of the results will be condensed, over the course of the next few months, in two distinct publications. They have been presented internally, but also in the context of collaborations with external groups, and in the context of at least one conference and one workshop."